» Authors » Kazuyoshi Nagata

Kazuyoshi Nagata

Explore the profile of Kazuyoshi Nagata including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 77
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ichikawa T, Yamashima M, Yamamichi S, Koike M, Nakano Y, Yajima H, et al.
Biomed Rep . 2024 Aug; 21(4):142. PMID: 39161940
The relationship between immunoglobulin A (IgA) levels and chronic liver disease remains poorly understood. The present study evaluated the clinical significance of IgA in 478 new patients who visited the...
2.
Okamura T, Ikeda T, Nagata K, Ichikawa T, Nakao K
Endoscopy . 2024 May; 56(S 01):E404-E405. PMID: 38810970
No abstract available.
3.
Honda T, Ichikawa T, Yamashima M, Yamamichi S, Koike M, Nakano Y, et al.
Biomed Rep . 2024 Jan; 20(1):2. PMID: 38222867
Protein induced by vitamin K (VK) absence-II (PIVKA-II) is a sensitive marker for diagnosing hepatoma but is occasionally detected in patients without hepatoma Here, the clinical significance of serum PIVKA-II...
4.
Sawase H, Ozawa E, Yano H, Ichinomiya T, Yano R, Miyaaki H, et al.
BMC Anesthesiol . 2023 May; 23(1):156. PMID: 37158818
Background: Nasal high flow (NHF) may reduce hypoxia and hypercapnia during an endoscopic retrograde cholangiopancreatography (ERCP) procedure under sedation. The authors tested a hypothesis that NHF with room air during...
5.
Komatsu N, Ozawa E, Fukushima M, Sawase H, Nagata K, Miuma S, et al.
DEN Open . 2023 Mar; 3(1):e225. PMID: 36998348
Objectives: Anastomotic biliary strictures (ABSs) are common complications following living donor liver transplantation (LDLT). We evaluated the feasibility of a novel removable, intraductal, fully covered, self-expandable metallic stent (FCSEMS) for...
6.
Nagata K, Sasaki R, Iwatsu S, Fukushima M, Haraguchi M, Yamamichi S, et al.
Anticancer Res . 2022 Oct; 42(10):5001-5007. PMID: 36192013
Background/aim: This study was conducted to determine the prognosis and risk factors for survival in patients treated with stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC). Patients And Methods: This...
7.
Sasaki R, Nagata K, Fukushima M, Haraguchi M, Miuma S, Miyaaki H, et al.
Cancers (Basel) . 2022 Feb; 14(3). PMID: 35159095
Background: Atezolizumab plus bevacizumab therapy has high response rates in patients with unresectable hepatocellular carcinoma (HCC). The hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging (EOB-MRI) has been reported to...
8.
Ayuse T, Sawase H, Ozawa E, Nagata K, Komatsu N, Sanuki T, et al.
Medicine (Baltimore) . 2020 May; 99(19):e20036. PMID: 32384464
Background: For relatively invasive upper gastrointestinal endoscopy procedures, such as an endoscopic retrograde cholangiopancreatography (ERCP), and also lower gastrointestinal endoscopy procedures, intravenous anesthesia is routinely used to reduce patient anxiety....
9.
Nagata K, Akazawa Y
Mayo Clin Proc . 2019 Mar; 94(3):557-558. PMID: 30832801
No abstract available.
10.
Hashimoto S, Yatsuhashi H, Abiru S, Yamasaki K, Komori A, Nagaoka S, et al.
PLoS One . 2016 Sep; 11(9):e0163644. PMID: 27680885
Background & Aim: We performed lipid analyses at the early period of therapy in patients with chronic hepatitis C who underwent interferon (IFN)-free direct-acting antiviral (DAA) treatment, and we attempted...